medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2011, Number 598

<< Back Next >>

Rev Med Cos Cen 2011; 68 (598)

Prevalencia de la retinopatía diabética en la clínica Dr. Clorito Picado

Martínez AJ, Marchena CD

Language: Spanish
References: 27
Page: 333-337
PDF size: 250.73 Kb.


ABSTRACT

The objective of this paper is to study the prevalence and characteristics of diabetic retinopathy (DR) patients referred to the ophthalmology clinic of a second level clinic of the Costa Rican Social Security. 1314 diabetics type 2 were examined, with an average age of 61.7 years of age. Of these, 61.8% were female and 38.2% were male. Duration of diabetes was 7.9 years on average. Prevalence of DR was 16,4% (299 patients); where 7,1% had mild DR, moderate DR 6,1% and severe DR 2,1%. Proliferative DR accounted for a 1,9%, and 2.1% of patients had macular edema. Diabetics with more than 10 years of disease presented retinopathy in 81.6%, and 68.5% had hypertension and 54.8% dyslipidemia. An 8.5% presented cataracts, and 6.0% had glaucoma, whereas 65,1 % had a register of glycosylated hemoglobin on the six months prior to the evaluation.


REFERENCES

  1. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern ® Guidelines. Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008.

  2. Benson WE. Diabetic retinopathy. En: Ophthalmology, eds. Yanoff M, Ducker JS. Mosby, 1999: 8.20.1-8.20.10

  3. Boucher M, Desroches G, et al. Teleophthalmology screening for diabetic retinopathy through mobile imaging units within Canada. Can J Ophthalmol, 2008 vol 43, No 6: 658-668.

  4. Chew EY, Ferris EY. Non proliferative diabetic retinopathy. En: Ryan SJ ed. Retina. Mosby, 2001:1295-1308.

  5. DCCT Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Oph-thalmology 1995;102:647–61.

  6. Diabetic Retinopathy Study Research Group: Indications for photocoagulation treatment of diabetic retinopathy (DRS Report No 14) Int Ophthalmol Clin 1987 27: 239-253.

  7. Early Treatment Diabetic Retinopathy study Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report Number 12. Ophthalmology 1991; 98:823-833.

  8. Farreras P, Rozman C. Medicina Interna. 14a Ed. España: Editorial Harcourt, 2000: Vol. 2: 2222-2223

  9. Fong D, Aiello Ll, et al. Retinopathy in Diabetes. Diabetes Care. January 2004 vol. 27 no. suppl 1 s84-s87.

  10. Hassan TS. Current concepts in vitrectomy for diabetic macular edema. En: Retina 2001. American Academy of Ophthalmology. San Francisco, 2001:267-274.

  11. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy, IV: diabetic macular edema. Ophthalmology 1984; 91:1464-74.

  12. Klein R, Moss SE, Klein BE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989; 96:1501-1510.

  13. Klein R, Moss SE, Klein BE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 Years. Arch Ophthalmol. 1984; 102(4):520-526.

  14. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Association of ocular diseases and mortality in a diabetic population. Arch Ophthalmol 1999; 117:1487-95.

  15. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IV: diabetic macular edema. Ophthalmology 1984; 91:1464 – 74.

  16. Laclé A, Mora C, García M. Tamizaje de retinopatía diabética en diabéticos tipo 2 en área de salud del área metropolitana. Acta méd. costarric v.44 n.2 San José jun. 2002

  17. Leske MC, Wu SY, et al. Incidence of diabetic retinopathy in the Barbados Eye Study. Ophthalmology 2003:110:941-947.

  18. Martínez J, Hernández E, Wu L. Diabetic retinopathy screening using single-field digital fundus photography at a district level in Costa Rica: a pilot study. Int Ophthalmol (2011) 31:83–88

  19. Moss SE, Klein R, Klein BEK. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 1994; 101:1061-70.

  20. Pelzek C, Lim J. Diabetic macular edema: Reviw and update. Clinics of North America 15 (2002) 555-563.

  21. Rodríguez J, et al. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology 2002; 109:737-743.

  22. Santos E, Macarro A, et al. Prevalencia de la retinopatía diabética en el Centro de Salud de Torrejoncillo (Cáceres). Av Diabetol. 2002; 18: 203-207

  23. Sidikaro Y. Laser photocoagulation in diabetic retinopathy. Ophthalmol Clin N Am 1993; 6:473-477.

  24. The Eye Diseases Prevalence Research Group. The Prevalence of Diabetic Retinopathy Among Adults in the United States. Arch Ophthalmol. 2004; 122:552-563.

  25. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-853.

  26. Wilkinson-Berka Jl, Millar AG. Update on the treatment of diabetic rethinopathy. 2008 Feb 6; 8: 98-120

  27. Zhang X, Saaddine J, et at. Prevalencia de la retinopatía diabética en los Es-tados Unidos, 2005-2008. JAMA. 2010; 304 (6): 649-656.




2020     |     www.medigraphic.com